Robotic Surgery for Gastric Cancer: Disparities Persist
Robotic-assisted surgery for gastric cancer shows promise but access remains inequitable.
Newsletter
Every new paper in this field, in your inbox.
Robotic-assisted surgery for gastric cancer shows promise but access remains inequitable.
New approaches for managing gastro-oesophageal reflux disease (GORD) are evolving, impacting patient outcomes and surgical practices.
Combining enhanced recovery after surgery (ERAS) nursing with early enteral nutrition significantly improves recovery for gastric cancer patients after radical gastrectomy.
Postoperative C-reactive protein levels are key indicators for survival outcomes in gastric cancer patients.
Higher glycemic variability signals increased mortality risk in gastric surgery patients.
Endoscopic and surgical interventions significantly enhance outcomes for anastomotic leakage post-esophagectomy.
A novel radiomics-based risk assessment model significantly improves prediction of early postoperative recurrence in locally advanced gastric cancer, crucial for surgical decision-making.
Liver retraction can make or break laparoscopic upper GI surgeries; this new technique simplifies the process and cuts costs.
Applying human-derived fibrin sealant after gastric endoscopic submucosal dissection (ESD) significantly enhances patient outcomes.
Different tumor microbiomes in esophageal cancer patients directly impact survival rates.